183 related articles for article (PubMed ID: 8645373)
1. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
Morishita E; Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Hashimoto T; Matsuda T
Atherosclerosis; 1996 Feb; 120(1-2):7-14. PubMed ID: 8645373
[TBL] [Abstract][Full Text] [Related]
2. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
3. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy.
Asakawa H; Tokunaga K; Kawakami F
J Diabetes Complications; 2000; 14(3):121-6. PubMed ID: 10989319
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
[TBL] [Abstract][Full Text] [Related]
5. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
6. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
[TBL] [Abstract][Full Text] [Related]
7. Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
Daví G; Violi F; Catalano I; Giammarresi C; Putignano E; Nicolosi G; Barbagallo M; Notarbartolo A
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):41-5. PubMed ID: 1772997
[TBL] [Abstract][Full Text] [Related]
8. The effect of obesity on fibrinolytic activity and plasma lipoprotein (a) levels in patients with type 2 diabetes mellitus in Korea.
Park YS; Park S; Park KS; Kim SY; Lee HK; Koh CS; Min HK; Kim JQ
Diabetes Res Clin Pract; 1994 May; 24(1):25-31. PubMed ID: 7924883
[TBL] [Abstract][Full Text] [Related]
9. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
[TBL] [Abstract][Full Text] [Related]
10. Hyperlipidemia and hemostatic system.
Morishita E; Jokaji H; Matsuda T
J Atheroscler Thromb; 1995; 2 Suppl 1():S36-40. PubMed ID: 9225230
[TBL] [Abstract][Full Text] [Related]
11. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
Tohgi H; Takahashi H; Chiba K; Tamura K
Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
[TBL] [Abstract][Full Text] [Related]
12. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
13. Change of lipoprotein (a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy.
Nagai T
J Atheroscler Thromb; 1994; 1(1):37-40. PubMed ID: 9222867
[TBL] [Abstract][Full Text] [Related]
14. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
[TBL] [Abstract][Full Text] [Related]
15. Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease.
Wieczór R; Wieczór AM; Kulwas A; Rość D
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336615
[No Abstract] [Full Text] [Related]
16. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
[TBL] [Abstract][Full Text] [Related]
18. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
Collatos C; Barton MH; Prasse KW; Moore JN
J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
[TBL] [Abstract][Full Text] [Related]
19. The molecular markers of hemostatic activation on coronary artery disease.
Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoprotein (a) levels and fibrinolytic activity in acute myocardial infarction.
Honda Y; Oshima S; Ogawa H; Sakamoto T; Miyao Y; Sakata S; Hirashima O; Moriyama Y; Yasue H
Jpn Circ J; 1994 Dec; 58(12):869-76. PubMed ID: 7699733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]